dc.contributor.author | Ford, Isobel | |
dc.date.accessioned | 2015-07-30T10:35:01Z | |
dc.date.available | 2015-07-30T10:35:01Z | |
dc.date.issued | 2015-08 | |
dc.identifier | 51065037 | |
dc.identifier | fa85afbc-a91a-4d77-b60a-5f5cb9e253a2 | |
dc.identifier | 84938383720 | |
dc.identifier.citation | Ford , I 2015 , ' Coming safely to a stop : a review of platelet activity after cessation of antiplatelet drugs ' , Therapeutic Advances in Drug Safety , vol. 6 , no. 4 , pp. 141-150 . https://doi.org/10.1177/2042098615588085 | en |
dc.identifier.issn | 2042-0986 | |
dc.identifier.uri | http://hdl.handle.net/2164/4725 | |
dc.description | Funding Isobel Ford is an employee of the University of Aberdeen. The research for the writing of this review received no specific grant from any funding agency in the public, commercial, or not-forprofit sectors | en |
dc.format.extent | 10 | |
dc.format.extent | 290539 | |
dc.language.iso | eng | |
dc.relation.ispartof | Therapeutic Advances in Drug Safety | en |
dc.subject | antiplatelet therapy | en |
dc.subject | cessation | en |
dc.subject | clopidogrel | en |
dc.subject | P2Y12 inhibitors | en |
dc.subject | platelet activation | en |
dc.subject | rebound | en |
dc.subject | RM Therapeutics. Pharmacology | en |
dc.subject.lcc | RM | en |
dc.title | Coming safely to a stop : a review of platelet activity after cessation of antiplatelet drugs | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences - Cardiovascular Group | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1177/2042098615588085 | |